carbamates has been researched along with Cardiac Hypertrophy in 1 studies
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cardiomyocyte BRAFV600E induced cardiac hypertrophy within 10 d, resulting in increased ejection fraction and fractional shortening over 6 weeks." | 1.72 | Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo. ( Alharbi, HO; Barton, PJ; Chothani, SP; Clerk, A; Cook, SA; Cooper, STE; Cull, JJ; Felkin, LE; Fuller, SJ; Glennon, PE; Hardyman, MA; Leonard, SJ; Markou, T; McTiernan, CF; Meijles, DN; Rackham, OJL; Rojas, M; Sembrat, JC; Shaw, SW; Sheppard, MN; Sugden, PH; Vanezis, K, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clerk, A | 1 |
| Meijles, DN | 1 |
| Hardyman, MA | 1 |
| Fuller, SJ | 1 |
| Chothani, SP | 1 |
| Cull, JJ | 1 |
| Cooper, STE | 1 |
| Alharbi, HO | 1 |
| Vanezis, K | 1 |
| Felkin, LE | 1 |
| Markou, T | 1 |
| Leonard, SJ | 1 |
| Shaw, SW | 1 |
| Rackham, OJL | 1 |
| Cook, SA | 1 |
| Glennon, PE | 1 |
| Sheppard, MN | 1 |
| Sembrat, JC | 1 |
| Rojas, M | 1 |
| McTiernan, CF | 1 |
| Barton, PJ | 1 |
| Sugden, PH | 1 |
1 other study available for carbamates and Cardiac Hypertrophy
| Article | Year |
|---|---|
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Topics: Animals; Carbamates; Cardiomegaly; Cell Size; Cells, Cultured; Dimerization; Gene Knock-In Technique | 2022 |